& Tsien, R
The landmark PANTHEON trial, a 1-year multicenter RCT in 1,006 Chinese COPD patients, found that high-dose NAC (600 mg twice daily) reduced the rate of acute exacerbations by 22% compared to placebo (1.16 vs 1.49 exacerbations per year, p=0.0011) (Zheng et al., Lancet Respir Med, 2014) [44]
However, it is associated with a risk of liver injury in patients with primary biliary cholangitis (328), and significantly elevates LDL-cholesterol (306)
Drach J, Lopez-Berestein G, McQueen T, Andreeff M , Mehta K
As much as these injections help improve the health of ones skin and promote anti aging benefits, there are safety issues plus cost although provider competence must never be ignored
By countering oxidative stress, glutathione IV therapy may assist in preventing chronic diseases and could potentially slow the ageing process